FDA Approves First Drug Treatment for Postpartum Depression

The U.S. Food and Drug Administration (FDA) has approved a drug for the first time that aims at treating postpartum depression in mothers. Dubbed Zulresso, the medication is administered by a continuous intravenous (IV) infusion for 60 hours. According to the FDA, the IV must be administered in a health care facility because of fears […]